Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects.
about
Blood glucose control in patients with severe sepsis and septic shockAdverse side effects of dexamethasone in surgical patientsDirect Revascularization With the Angiosome Concept for Lower Limb Ischemia: A Systematic Review and Meta-AnalysisStress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!Patient, Surgery, and Hospital Related Risk Factors for Surgical Site Infections following Total Hip ArthroplastyGlucose control in the intensive care unit: a nutrition support perspective.Recent advances in epidural analgesia.The impact of hyperglycemia on risk of severe infections during early period of induction therapy in patients with newly diagnosed multiple myelomaHyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients.Nutritional status and hyperglycemia in the peritransplant period: a review of associations with parenteral nutrition and clinical outcomesInadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery.Untangling glycaemia and mortality in critical careImpact of hyperglycemia on survival and infection-related adverse events in patients with metastatic colorectal cancer who were receiving palliative chemotherapy.Fasting hyperglycemia upon hospital admission is associated with higher pneumonia complication rates among the elderly.The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia.Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program.Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630].Current management and novel insights in acute pancreatitis.Does early postresuscitation stress hyperglycemia affect 72-hour neurologic outcome? Preliminary observations in the Swine model.Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty.GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions.Persistent hyperglycemia modulates gut immune function and microbiota in rats.Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients.Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.Upregulation of proinflammatory cytokine production in response to bacterial pathogen-associated molecular patterns in dogs with diabetes mellitus undergoing insulin therapy.Transient hyperglycaemia - an underestimated problem of paediatric oncohaematology.Carbohydrate provision in the era of tight glucose control.Barriers to glucose control in the intensive care unit.Feeding our immune system: impact on metabolism.Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humansEffects of a New Metabolic Conditioning Supplement on Perioperative Metabolic Stress and Clinical Outcomes: A Randomized, Placebo-Controlled TrialAnesthesia with propofol induces insulin resistance systemically in skeletal and cardiac muscles and liver of rats.The effect of diabetes on hospital readmissions.Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveTight blood glucose control is renoprotective in critically ill patientsReducing surgical site infection in arthroplasty of the lower limb: A multi-disciplinary approachAntecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation.Surgical site infection: the host factor.
P2860
Q22305498-E045CF7A-09B7-418E-B524-4CA4416C0D79Q24188268-ABDA1ABD-2ADC-4719-9D2D-0E9FFEC0F08EQ26796547-3D05807C-9D71-4E8A-84D3-2C70419F89D7Q27003097-169F6372-83B7-4200-B18E-3589FAD9C411Q28082491-4F6047C4-95C3-417D-96B8-51939E82691AQ30452738-82F625D4-6C93-47C9-975F-4D1E4AD69E38Q30472078-6608DE84-A864-46A3-8BFE-CA7FDCF2582AQ33562719-24E79B0E-B0C5-4D1F-8517-2F6435530F10Q33751447-B1901095-4B50-4BFD-A5D7-1608579893EDQ33758951-B460E704-7641-4BB9-B17F-24CC679F8676Q33761860-BB6929DF-3047-497A-9FD4-249DF1ED859DQ33830336-B49E8C9D-9CA5-4028-922E-9CCB71B0A8C0Q34043430-C575AEFA-A326-4146-A99B-3D065A24BC70Q34071488-26E78650-4541-4962-A364-CBB7B82A864BQ34351686-11592520-111D-486E-98FB-9C3E5E96B9F2Q34399092-659D1038-1D52-4567-B5C4-DB359C8ABED1Q34480775-CA26E993-0F82-44AD-B351-A8C62DCBDA0BQ34996916-CAD1679B-2E3B-413F-8D3F-0BD8D63B3D26Q35009572-3BE9C372-E57E-4AFB-836B-022AC0EEBD3CQ35076028-E1A4A151-2476-4FDF-A6B0-C3817B8F4E33Q35587378-9BC34A3F-7392-4B07-B023-4A40E2EEEDF3Q35703272-4DD76B06-1AF4-45F3-B2CD-7E5A1FC6B806Q35881062-306848F0-D3AD-4F00-B799-94E389AEB2EBQ35893898-544E048A-26D5-4E18-B3FB-E8A66D9BCDEEQ35918407-F47C9713-E0F9-4F5A-BD01-CCB86306DCFCQ36064796-8DC28911-4A99-49E3-950E-340B11500265Q36228940-3BF58E60-3FD3-4279-B92E-77E46122C8D0Q36286307-BEE9FA78-BCB2-441D-86E5-A2D1829908D1Q36318305-A6B7CD1E-32F5-4B58-95AE-D803EB91058AQ36390908-F8F65397-F46C-4A42-B792-E545F2C2506BQ36494499-FFFA20BB-9009-46CB-9197-93AC39ACECCBQ36499645-8C4438AC-769F-44B2-9EC8-DCF6ADFDA59AQ36577850-07720C06-88AF-4930-985C-11549D3853F4Q36593755-3498F564-331B-4048-88C7-D6DCCB174210Q36605687-88C12AD0-8921-4CEE-BF16-04D844F8E9B9Q36646072-19D8518E-D75D-4ECC-8B2A-7CA14C70C8A2Q36667192-CB1B4434-6AA0-4DC0-B646-3A7FB55EECFDQ36765470-0E6DB2DC-8DB3-4C9D-81D0-2915E5A79C0DQ36906212-04C7A664-09F8-49C7-94BD-FE37E7D53B1DQ37020965-BCB0884C-6B6E-4EDD-9459-DE0212A61F39
P2860
Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Acute hyperglycemia and the in ...... llular, and molecular aspects.
@ast
Acute hyperglycemia and the in ...... llular, and molecular aspects.
@en
type
label
Acute hyperglycemia and the in ...... llular, and molecular aspects.
@ast
Acute hyperglycemia and the in ...... llular, and molecular aspects.
@en
prefLabel
Acute hyperglycemia and the in ...... llular, and molecular aspects.
@ast
Acute hyperglycemia and the in ...... llular, and molecular aspects.
@en
P2093
P1476
Acute hyperglycemia and the in ...... llular, and molecular aspects.
@en
P2093
Donald E Fry
Hiram C Polk
Matthias Turina
P304
P356
10.1097/01.CCM.0000170106.61978.D8
P407
P577
2005-07-01T00:00:00Z